The company is now moving to apply for an expanded label from the US Food and Drug Administration . If approved, it would allow Zepbound to be prescribed and used for the treatment of sleep apnea , in addition to its current weight loss use.Dental-care double standard: hygienists ask for equal pay under federal plan
Hayley Erbert makes emotional return to the stage with husband Derek Hough months after brain surgery 'Cancer doesn't care who you are': Olivia Munn opens up about 'tough' mastectomy and a risk tool that 'saved' her life
Source: Law Daily Report (lawdailyreport.net)
Weight Loss Drug Sleep Apnea Pharmaceutical Giant Irregular Breathing Sleep Clinical Trial
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Eli Lilly, Novo Euphoria Risks Disappointing Investors, Goldman SaysThe weight loss drug frenzy that’s driven Eli Lilly & Co. and Novo Nordisk A/S to record peaks is raising the stakes for investors, according to Goldman Sachs Group Inc. analysts.
Source: BNNBloomberg - 🏆 83. / 50 Read more »
Weight-loss drug shortage result of 'unprecedented demand'Certain doses of Eli Lilly's (LLY) GLP-1 weight loss drugs Zepbound and Mounjaro are facing a supply shortage, much like competitor Novo Nordisk's (NVO) own ...
Source: YahooFinanceCA - 🏆 47. / 63 Read more »
Lilly’s Weight-Loss Drug Helped Sleep Apnea Symptoms in StudiesEli Lilly & Co.’s weight-loss drug Zepbound improved breathing problems in highly-anticipated studies that may convince more insurers to cover the $1,000-a-month treatment.
Source: BNNBloomberg - 🏆 83. / 50 Read more »
Lilly’s $2.5 Billion German Plant Will Boost Obesity-Drug SupplyEli Lilly & Co. kicked off construction of a plant to boost the production of its wildly popular weight-loss drugs, which have yet to gain a foothold in Europe.
Source: BNNBloomberg - 🏆 83. / 50 Read more »
Amazon, Rite Aid Can’t Get Enough Supply of Weight-Loss Drug ZepboundRite Aid Corp. and Amazon Pharmacy confirmed that Eli Lilly & Co.’s new weight-loss drug Zepbound is in short supply, as patient, pharmacist and doctor complaints mount.
Source: BNNBloomberg - 🏆 83. / 50 Read more »
Chuck Lilly, a Chartered Accountant with SRWC Chartered Professional Accountants LLP balances professional excellence with community bondsChuck Lilly embraces family, friendships and community service in Sudbury
Source: sudburydotcom - 🏆 6. / 89 Read more »